Omega-3 supplements linked to reduction in depression

March, 2016

A new meta-analysis supports the link between intake of EPA and DHA omega-3 fatty acids, and reduction in major depressive disorder (MDD).

The meta-analysis only included studies in adult patients with MDD assessed using standardized clinical interviews, and excluded studies that specifically studied perinatal/perimenopausal or comorbid MDD, in order to get a more homogenous population. Studies not applying a randomized placebo-controlled trial design were also excluded. This criteria resulted in 13 studies with a total of 1233 participants (out of an original pool of 1955 studies).

The analysis of these studies showed a benefit for these omega-3 acids that was comparable to effects reported in meta-analyses of antidepressants. The effect was greater in studies supplementing higher doses of EPA and performed in patients already on antidepressants.

http://www.eurekalert.org/pub_releases/2016-03/g-nss031716.php

Mocking, R. J. T., Harmsen, I., Assies, J., Koeter, M. W. J., Ruhe, H. G., & Schene, A. H. (2016). Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder. Transl Psychiatry, 6, e756. Retrieved from http://dx.doi.org/10.1038/tp.2016.29

Related News

Following on from studies showing that a Mediterranean-like diet may be associated with a lower risk of Alzheimer's disease and may lengthen survival in people with Alzheimer's, a six-year study of 712 New Yorkers has revealed that those who were most closely following a Mediterranean-like diet

An analysis technique using artificial neural networks has revealed that the most important factors for predicting whether amnestic mild cognitive impairment (

A study involving 733 participants from the Framingham Heart Study Offspring Cohort (average age 60) provides more evidence that excess abdominal fat places otherwise healthy, middle-aged people at greater risk for dementia later in life.

A variant of a gene called the fat mass and obesity associated (FTO) gene causes people to gain weight and puts them at risk for obesity. The gene variant is found in nearly half of all people in the U.S. with European ancestry, around one-quarter of U.S.

The largest ever trial of fish oil supplements has found no evidence that they offer benefits for cognitive function in older people. The British study enrolled 867 participants aged 70-80 years, and lasted two years.

Pages

Subscribe to Latest newsSubscribe to Latest newsSubscribe to Latest health newsSubscribe to Latest news